The clinical management of tumour lysis syndrome in haematological malignancies

British Journal of Haematology

Volumn 154, Issue 1, 2011, Pages 3-13

  Will, Andrew ^a   Tholouli, Eleni ^b  

^a ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Allopurinol; Haematological malignancy; Hyperuricaemia; Rasburicase; Tumour lysis

Indexed keywords

ALLOPURINOL; ALUMINUM HYDROXIDE; BICARBONATE; FUROSEMIDE; GLUCONATE CALCIUM; GLUCOSE; INSULIN; POLYSTYRENESULFONATE SODIUM; RASBURICASE; SALBUTAMOL; URICOZYME;

ALKALINIZATION; ALLERGIC REACTION; ANAPHYLAXIS; BRONCHOSPASM; CARDIOTOXICITY; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG METABOLISM; EDEMA; FLUID RETENTION; FLUID THERAPY; HEMATOLOGIC MALIGNANCY; HEMOLYTIC ANEMIA; HUMAN; HYPERKALEMIA; HYPERPHOSPHATEMIA; HYPERURICEMIA; HYPOCALCEMIA; INCIDENCE; KIDNEY FAILURE; LEUKAPHERESIS; LIVER DYSFUNCTION; METHEMOGLOBINEMIA; OLIGURIA; PATHOGENESIS; PATIENT MONITORING; PRIORITY JOURNAL; PRURITUS; RASH; RENAL REPLACEMENT THERAPY; REVIEW; RISK FACTOR; SINGLE DRUG DOSE; TUMOR LYSIS SYNDROME; URINARY ALKALINIZATION; WHEEZING;

ALLOPURINOL; ENZYME INHIBITORS; HEMATOLOGIC NEOPLASMS; HUMANS; INCIDENCE; TUMOR LYSIS SYNDROME; URATE OXIDASE; XANTHINE OXIDASE;

EID: 79958799214     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2011.08697.x     Document Type: Review

References (61)

1. Alkhuja, S. & Ulrick, H. (2002) Acute renal failure from spontaneous tumor lysis syndrome: a case report and review. Renal Failure, 24, 227-232.
2. Andreoli, S.P., Clark, J.H., McGuire, W.A. & Bergstein, J.M. (1986) Purine excretion during tumor lysis in children with acute lymphocytic leukaemia receiving allopurinol: relationship to acute renal failure. Journal of Pediatrics, 109, 292-298.
3. Annemans, L., Moeremans, K., Lamotte, M., Conde, J.G., Van den Berg, H., Myint, H., Pieters, R. & Uyttebroeck, A. (2003) Incidence, medical resource utilisation and costs of hyperuricaemia and tumour lysis syndrome in patients with acute leukaemia and non-Hodgkin's lymphoma in four European countries. Leukaemia and Lymphoma, 44, 77-83.
4. Atra, A., Gerrard, M., Hobson, R., Imeson, J.D., Ashley, S. & Pinkerton, C.R. (1998) Improved cure rate in children with B-cell acute lymphoblastic leukaemia (B-ALL) and stage IV B-cell non-Hodgkin's lymphoma (B-NHL) - results of the UKCCG 9003 protocol. British Journal of Cancer, 77, 2281-2285.
5. Bedrna, J. & Polcák, J. (1929) Akutar Harnleiterverschluss nach Bertrahlung chronischer Leukämien mit Röntgenstrahlen. Medizinische Klinik, 25, 1700-1701.
6. de Bont, J.M. & Pieters, R. (2004) Management of hyperuricaemia with rasburicase review. Nucleosides, Nucleotides and Nucleic Acids, 23, 1431-1440.
7. Bosly, A., Saonet, A., Pinkerton, C.R., McCowage, G., Bron, D., Sanz, M.A. & Van den Berg, H. (2003) Rasburicase (recombinant urate oxidase) for the management of hyperuricaemia in patients with cancer. Cancer, 98, 1048-1054.
8. Bowman, W.P., Shuster, J.J., Cook, B., Griffin, T., Behm, F., Pullen, J., Link, M., Head, D., Carroll, A., Berard, C. & Murphy, S. (1996) Improved survival of children with B-cell acute lymphoblastic leukaemia and stage IV noncleaved-cell lymphoma: a pediatric oncology group study. Journal of Clinical Oncology, 14, 1252-1261.
9. Brant, J.M. (2002) Rasburicase: an innovative new treatment for hyperuricemia associated with tumor lysis syndrome. Clinical Journal of Oncology Nursing, 6, 12-16.
10. Brogard, J.M., Coumaros, D., Franckhauser, J., Stahl, A. & Stahl, J. (1972) Enzymatic uricolysis: a study of the effect of a fungal uric oxidase. Revues Europeenne d' Etudes Cliniques et Bioliologiques, 17, 890-895.
11. Browning, L.A. & Kruse, J.A. (2005) Hemolysis and methemoglobinemia secondary to rasburicase administration. Annals of Pharmacotherapy, 39, 1932-1935.
12. Cairo, S.M. (2002) Prevention and treatment of hyperuricemia in haematological malignancies. Clinical Lymphoma, 3(Suppl. 1), S26-S31.
13. Cairo, S.M. & Bishop, M. (2004) Tumour lysis syndrome: new therapeutic strategies and classification. British Journal of Haematology, 127, 3-11.
14. Cairo, S.M., Coiffier, B., Reiter, R. & Younes, A. (2010) Recommendation for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert panel consensus. British Journal of Haematology, 149, 578-586.
15. Cammalleri, L. & Malaguanera, M. (2007) Rasburicase represents a new tool for hyperuricaemia in tumor lysis syndrome and in gout. International Journal of Medical Sciences, 4, 83-93.
16. Candrilli, S., Bell, T., Irish, W., Morris, E., Goldman, S. & Cairo, M.S. (2008) A comparison of inpatient length of stay and costs among patients with haematological malignancies (excluding Hodgkin Disease) associated with and without acute renal failure. Clinical Lymphoma & Myeloma, 8, 44-51.
17. Cheson, B.D. & Dutcher, B.S. (2005) Managing malignancy-associated hyperuricemia with rasburicase. The Journal of Supportive Oncology, 3, 117-124.
18. Coiffier, B., Altman, A., Pui, C.-H., Younes, A. & Cairo, M.S. (2008) Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review. Journal of Clinical Oncology, 26, 2767-2778.
19. Conger, J.D. (1990) Acute uric acid nephropathy. Medical Clinics of North America, 74, 859-871.
20. Conger, J.D. & Falk, S.A. (1977) Intrarenal dynamics in the pathogenesis and prevention of acute urate nephropathy. The Journal of Clinical Investigation, 59, 786-793.
21. Coutinho, A.K., de O Santos, M., Pinczowski, H., Feher, O. & del Giglio, A. (1997) Tumor lysis syndrome in a case of chronic lymphocytic leukemia induced by high-dose corticosteroids. American Journal of Hematology, 54, 85-86.
22. Davidson, M.B., Thakker, S., Hix, J.K., Bhandarker, N.D., Wong, A. & Schrieber, M.J. (2004) Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome. American Journal of Medicine, 116, 546-554.
23. Deger, G.E. & Wagoner, R.D. (1972) Peritoneal dialysis in acute uric acid nephropathy. Mayo Clinic Proceeding, 47, 189-192.
24. Ducros, J., Saingra, S., Rampal, M., Coulange, C., Barbe, M.-C. & Verzetti, G. (1991) Hemolytic anaemia due to G6PD deficiency and urate oxidase in a kidney transplant patient. Clinical Nephrology, 35, 89-90.
25. Easton, J., Noble, S. & Jarvis, B. (2001) Rasburicase. Paediatric Drugs, 3, 433-437.
26. Eguiguren, J.M., Schell, M.J., Crist, W.M., Kunkel, K. & Rivera, G.K. (1992) Complications and outcome in childhood acute lymphoblastic leukaemia with hyperleukocytosis. Blood, 79, 871-875.
27. Flombaum, C.D. (2000) Metabolic emergencies in the cancer patient. Seminars in Oncology, 27, 322-334.
28. Goldman, S.C., Holcenberg, J.S., Finklestein, J.Z., Hutchison, R., Kreissman, S., Johnson, F.L., Tou, C., Harvey, E., Morris, E. & Cairos, M.S. (2001) A randomised comparison between Rasburicase and allopurinol in children with lymphoma or leukaemia at high risk for tumor lysis. Blood, 97, 2998-3003.
29. Hande, K.R. & Garrow, G.C. (1993) Acute tumor lysis syndrome in patients with high grade non-Hodgkin's lymphoma. American Journal of Medicine, 94, 133-139.
30. Hande, K.R., Hixson, C.V. & Chabner, B.A. (1981) Postchemotherapy purine excretion in lymphoma patients receiving allopurinol. Cancer Research, 41, 2273-2279.
31. Hsu, H.H., Chan, Y.L. & Huang, C.C. (2004) Acute spontaneous tumor lysis syndrome presenting with hyperuricemic renal failure: clinical features and therapeutic approach. Journal of Nephrology, 17, 50-56.
32. Jasek, A.M. & Day, H.J. (1994) Acute spontaneous tumor lysis syndrome. American Journal of Hematology, 47, 129-131.
33. Jeha, S. (2001) Tumor lysis syndrome. Seminars in hematology, 38(Suppl. 10), 4-8.
34. TM), in the management of malignancy-associated hyperuricaemia in pediatric and adult patients: final results of a multicentre compassionate use trial. Leukaemia, 19, 34-38.
35. Jones, D.P., Mahmoud, H. & Chesney, R.W. (1995) Tumor lysis syndrome: pathogenesis and management. Pediatric Nephrology, 9, 206-212.
36. Krakoff, I.H. & Meyer, R.L. (1965) Prevention of hyperuricaemia in leukaemia and lymphoma. The Journal of the American Medical Association, 193, 89-94.
37. List, A.F., Kummet, T.D., Adams, J.D. & Chan, H.G. (1990) Tumour lysis syndrome complicating the treatment of chronic lymphocytic leukaemia with fludarabine phosphate. American Journal of Medicine, 89, 388-390.
38. Locatelli, F. & Rossi, F. (2005). Incidence and pathogenesis of tumor lysis syndrome. Contributions to nephrology, 147, pp. 61-68.
39. McCroskey, R.D., Mosher, D.F., Spencer, C.D., Prendergast, E. & Longo, W.L. (1990) Acute tumor lysis syndrome and treatment response in patients treated for chronic lymphocytic leukaemia with short course, high-dose cytosine arabinoside, cisplatin and etoposide. Cancer, 66, 26-250.
40. Montesinos, P., Lorenzo, I., Martin, G., Sanz, J., Pérez-Sirvent, M.L., Martínez, D., Ortí, G., Algarra, L., Martínez, J., Moscardó, F., de la Rubia, J., Jarque, I., Sanz, J. & Sanz, M.A. (2008) Tumor lysis syndrome in patients with acute myeloid leukaemia: identification of risk factors and development of a predictive model. Haematologica, 93, 67-74.
41. Moreau, D. (2005) Pharmacological treatment of acute renal failure in intensive care patients. Contributions to Nephrology, 147, 161-173.
42. TM- rasburicase: an effective means to prevent and treat hyperuricemia associated with tumor lysis syndrome, a meeting report, Dallas, Texas, 2002. Leukaemia, 17, 499-514.
43. Patte, C., Sakiroglu, O., Ansoborlo, S., Baruchel, A., Plouvier, E., Pacquement, H. & Babin-Boilletot, A. (2002) Urate-oxidase in the prevention and treatment of metabolic complications in patients with B-cell lymphoma and leukaemia, treated in the Societe Francaise d'oncologie Pediatric LMB89 protocol. Annals of Oncology, 13, 789-795.
44. Perez-Padilla, R., de la Rosa-Zamboni, D., Ponce de Leon, S., Hernandez, M., Quiñones-Falconi, F., Bautista, E., Ramirez-Venegas, A., Rojas-Serrano, J., Ormsby, C.E., Corrales, A., Higuera, A., Mondragon, E. & Cordova-Villalobos, J.A., for the INER Working Group on Influenza (2009) Pneumonia and respiratory failure from Swine-origin influenza A (H1N1) in Mexico. New England Journal of Medicine, 361, 680-689.
45. Pfrimer, P., Pepe de Moraes, L.M., Galdino, A.S., Salles, L.P., Reis, V.C.B., De Marco, J.L., Prates, M.V., Bloch, Jr, C. & Torres, F.A.G. (2010). Cloning, purification, and partial characterization of Bacillus subtilis urate oxidase expressed in Escherichia coli. Journal of Biomedicine and Biotechnology, Epub 2010 Feb 4. PMID 20168977.
46. Pui, C.-H. (2002) Rasburicase: a potent uricolytic agent. Expert Opinion in Pharmacotherapy, 3, 433-452.
47. Pui, C.-H., Relling, M.V., Lascombes, F., Harrison, P.L., Struxiano, A., Mondesir, J.M., Ribeiro, R.C., Sandlund, J.T., Rivera, G.K., Evans, W.E. & Mahmoud, H.H. (1997) Urate oxidase in prevention and treatment of hyperuricaemia associated with lymphoid malignancies. Leukaemia, 11, 1813-1816.
48. Pui, C.-H., Mahmoud, H.H., Wiley, J.M., Woods, G.M., Leverger, G., Camitta, B., Hastings, C., Blaney, S.M., Relling, M.V. & Reaman, G.H. (2001) Recombinant urate oxidase for the prophylaxis or treatment of hyperuricaemia in patients with leukaemia or lymphoma. Journal of Clinical Oncology, 19, 697-704.
49. Rampello, E., Fricia, T. & Malaguarnera, M. (2006) The management of tumor lysis syndrome. Nature, Clinical Practice Oncology, 3, 438-447.
50. Ribiero, R.C. & Pui, H.-C. (2003) Recombinant urate oxidase for the prevention of hyperuricemia and tumor lysis syndrome in lymphoid malignancies. Clinical Lymphoma, 3, 225-232.
51. Sallan, S. (2001) Management of acute tumor lysis syndrome. Seminars in Oncology, 28(Suppl. 5), S9-S12.
52. Scott, G.S. & Hooper, D.C. (2001) The role of uric acid in protection against peroxynitrate-mediated pathology. Medical Hypotheses, 56, 95-100.
53. Scott, T.R., Graham, S.M., Schweitzer, E.J. & Bartlett, S.T. (1993) Colonic necrosis following sodium polystyrene sulphonate (Kaylexate®)-sorbitol enema in a renal transplant patient: report of a case and review of the literature. Disease of the Colon and Rectum, 36, 607-609.
54. Senanayake, S.N. (2009) Swine flu update: bringing home the bacon. Medical Journal of Australia, 191, 138-140.
55. Sparano, J., Ramirez, M. & Wiernik, P.H. (1990) Increasing recognition of corticosteroid-induced tumor lysis syndrome in non-Hodgkin's lymphoma. Cancer, 65, 1072-1073.
56. Tiu, R.V., Mountantonakis, S.E., Dunbar, A.J. & Schrieber, M.J. (2007) Tumor lysis syndrome. Seminars in thrombosis and hemostasis, 33, 397-407.
57. Wössmann, W., Schrappe, M., Meyer, U., Zimmermann, M. & Reiter, A. (2003) Incidence of tumor lysis syndrome in children with advanced stage Burkitt's lymphoma/leukemia before and after induction of prophylactic use of urate oxidase. Annals of Hematology, 82, 160-165.
58. Yamazaki, H., Hanada, M., Horiki, M., Kuyama, J., Sato, T., Nishikubo, M., Ishida, T. & Inoue, T. (2004) Acute tumor lysis syndrome caused by palliative radiotherapy in patients with diffuse large B-cell lymphoma. Radiation Medicine, 22, 52-55.
59. Yang, H., Rosove, M.H. & Figlin, R.A. (1999) Tumor lysis syndrome occurring after the administration of rituximab in lymphoproliferative disorders: high-grade non-Hodgkin's lymphoma and chronic lymphocytic leukemia. American Journal of Hematology, 62, 247-250.
60. Yeldandi, A.V., Yeldandi, V., Kumar, S., Murthy, C.V.N., Wang, X., Alvarez, K., Rao, M.S. & Reddy, J.K. (1991) Molecular evolution of the urate oxidase-encoding gene in hominoid primates: nonsense mutations. Gene, 109, 281-284.
61. Zusman, J., Brown, D.M. & Nesbit, M.E. (1973) Hyperphosphataemia, hyperphosphaturia and hypocalcaemia in acute lymphoblastic leukaemia. New England Journal of Medicine, 289, 1335-1340.